BioSphings Aktiengesellschaft

BioSphings, a biopharmaceutical company based in Frankfurt, Germany, focuses on the development of novel therapeutic approaches for the treatment of cancer, autoimmune diseases and viral infections.

The privately held company owns a portfolio of protected drug candidates which target pathways of the lipid metabolism.

BioSphings was founded as a spin-off of the DKFZ (German Cancer Research Center), Heidelberg, and was supported during its early stages by Cancer Research Technology Ltd., London.

© BioSphings AG 2011